Page last updated: 2024-10-29

ketanserin and Amphetamine-Related Disorders

ketanserin has been researched along with Amphetamine-Related Disorders in 2 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Amphetamine-Related Disorders: Disorders related or resulting from use of amphetamines.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Doyle, JR1
Yamamoto, BK1
Erritzoe, D1
Frokjaer, VG1
Holst, KK1
Christoffersen, M1
Johansen, SS1
Svarer, C1
Madsen, J1
Rasmussen, PM1
Ramsøy, T1
Jernigan, TL1
Knudsen, GM1

Other Studies

2 other studies available for ketanserin and Amphetamine-Related Disorders

ArticleYear
Serotonin 2 receptor modulation of hyperthermia, corticosterone, and hippocampal serotonin depletions following serial exposure to chronic stress and methamphetamine.
    Psychoneuroendocrinology, 2010, Volume: 35, Issue:4

    Topics: Amphetamine-Related Disorders; Animals; Behavior, Animal; Body Temperature Regulation; Central Nervo

2010
In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users.
    Archives of general psychiatry, 2011, Volume: 68, Issue:6

    Topics: Adult; Amphetamine-Related Disorders; Aniline Compounds; Brain; Case-Control Studies; Cross-Sectiona

2011